Publication | Open Access
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
131
Citations
21
References
2015
Year
NCT01085136 (clinicaltrials.gov).
| Year | Citations | |
|---|---|---|
Page 1
Page 1